|
|
The PhD Program in 'Design and Synthesis of Biologically Active Compounds' is installed at the Dipartimento Farmaceutico of the University of Parma since January 2008 and it is aimed at the formation of graduate students with a strong formation in experimental medicinal chemistry, with emphasis in:
The PhD Program is part of EUROPIN, an European Consortium (www.europin.at) under the LLP framework, directed to the implementation of an European Doctorate in Pharmacoinformatics.
The PhD Program has scientific agreements with Chiesi Pharmaceuticals, GSK Verona, Istituto Europeo di Oncologia (IEO) Milano, is supported by Tefarco-Innova consortium, and, besides the EUROPIN partners, has agreement with University of Granada (Spain).
|
Developing a joint PhD-programme in Pharmacoinformatics |
|
Managed by Alessio Lodola Last update: 02-29-12 |